EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 23 srpnja 2024. Database contains 4917 unique substances/entries.
Filter the list

 
209-765-7
592-62-1
Carc. 1B; Repr. 1B
Details
202-486-1
96-18-4
Carc. 1B; Repr. 1B; Acute Tox. 4
C Carcinogenic (article 57a)
R Toxic for reproduction (article 57c)
Details
217-406-0
1836-75-5
Carc. 1B; Repr. 1B; Acute Tox. 4
Details
BLENDUR I VP KU 3-4519
421-550-1
-
Carc. 1B; Repr. 1B; Skin Sens. 1
Details
209-358-4
573-58-0
Carc. 1B; Repr. 2
C Carcinogenic (article 57a)
Details
217-710-3
1937-37-7
Carc. 1B; Repr. 2
C Carcinogenic (article 57a)
Details
220-012-1
2602-46-2
Carc. 1B; Repr. 2
Details
202-480-9
96-13-9
Carc. 1B; Repr. 2; Acute Tox. 3; Acute Tox. 4
C Carcinogenic (article 57a)
Details
244-959-5
22398-80-7
Carc. 1B; Repr. 2; STOT RE 1
Details
226-009-1
5216-25-1
Carc. 1B; Repr. 2; STOT RE 1; Acute Tox. 4; STOT SE 3; Skin Irrit. 2
Details
604-636-5
148477-71-8
Carc. 1B; Repr. 2; STOT RE 2; Skin Sens. 1B
Details
204-273-9
118-74-1
Carc. 1B; STOT RE 1
Details
206-354-4
330-54-1
Carc. 1B; STOT RE 2
Details
219-603-7
2475-45-8
Carc. 1B; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
Details
202-591-2
97-56-3
Carc. 1B; Skin Sens. 1
C Carcinogenic (article 57a)
Details
219-363-3
2425-06-1
Carc. 1B; Skin Sens. 1
Details
-
-
Carc. 1B; Skin Sens. 1
Details
222-048-3
3327-22-8
Carc. 2
Details
692-456-8
688046-61-9
Carc. 2
Details
218-817-8
2243-62-1
Carc. 2
Details
B-TUM
418-770-5
151882-81-4
Carc. 2
Details
202-848-9
100-40-3
Carc. 2
Details
619-823-7
494793-67-8
Carc. 2
Details
200-473-5
60-35-5
Carc. 2
Details
287-476-5
85535-84-8
Carc. 2
PBT Persistent, Bioaccumulative and Toxic (article 57d)
VPVB very Persistent and very Bioaccumulative (article 57e)
Details
215-175-0
1309-64-4
Carc. 2
Details
216-901-9
1694-09-3
Carc. 2
Details
282-714-4
84332-86-5
Carc. 2
Details
216-485-9
1596-84-5
Carc. 2
Details
200-838-9
75-09-2
Carc. 2
Details
A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18, and boiling in the range of approximately 160°C to 320°C (320°F to 608°F).
265-078-2
64741-77-1
Carc. 2
Details
276-696-7
72490-01-8
Carc. 2
Details
605-666-1
173159-57-4
Carc. 2
Details
614-346-0
68157-60-8
Carc. 2
Details
A distillate oil having a minimum viscosity of 32.6 SUS at 37.7°C (100°F) to a maximum of 37.9 SUS at 37.7°C (100°F).
270-671-4
68476-30-2
Carc. 2
Details
A distillate oil having a minimum viscosity of 45 SUS at 37.7°C (100°F) to a maximum of 125 SUS at 37.7°C (100°F).
270-673-5
68476-31-3
Carc. 2
Details
Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200°C to 280°C (392°F to 536°F). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.
302-695-9
94114-59-7
Carc. 2
Details
A distillate oil having a minimum viscosity of 32.6 SUS at 37.7°C (100°F) to a maximum of 40.1 SUS at 37.7°C (100°F).
270-676-1
68476-34-6
Carc. 2
Details
A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163°C to 357°C (325°F to 675°F).
269-822-7
68334-30-5
Carc. 2
Details
Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180°C to 225°C (356°F to 473°F). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.
302-694-3
94114-58-6
Carc. 2
Details
262-302-0
60568-05-0
Carc. 2
Details
-
-
Carc. 2
Details
A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360°C to 500°C (680°F to 932°F). It produces a finished oil having a viscosity of 4.5cSt at approximately 100°C (212°F).
307-662-2
97675-88-2
Carc. 2
Details
253-178-9
36734-19-7
Carc. 2
Details
604-209-3
140923-17-7
Carc. 2
Details
604-351-6
143390-89-0
Carc. 2
Details
218-499-0
2164-08-1
Carc. 2
Details
432-140-7
110235-47-7
Carc. 2
Details
608-192-3
283159-90-0
Carc. 2
Details
show/hide
Glass Wool EC / List no: - | CAS no: 308066-92-4
Glass, oxide, chemicals
This category encompasses the various chemical substances manufactured in the production of inorganic glasses. For purposes of this category, 'glass' is defined as an amorfous, inorganic, transparent, translucent or opaque material traditionally formed by fusion of sources of silica with a flux, such as an alkali-metal carbonate, boron oxide, etc. and a stabilizer, into a mass which is cooled to a rigid condition without crystallization in the case of transparent or liquid-phase separated glass or with controlled crystallization in the case of glass-ceramics. The category consists of the various chemical substances, other than by-products or impurities, which are formed during the production of various glasses and concurrently incorporated into a glass mixture. All glasses contain one or more of these substances, but few, if any, contain all of them. The elements listed below are principally present as components of oxide systems but some may also be present as halides or chalcogenides, in multiple oxidation states, or in more complex compounds. Trace amounts of other oxides or chemical compounds may be present. Oxides of the first seven elements listed* comprise more than 95 percent, by weight, of the glass produced. @Aluminium*@Lead@Boron*@Lithium@Calcium*@Manganese@Magnesium*@Molybdenum@Potassium*@Neodymium@Silicon*@Nickel@Sodium*@Niobium@Antimony@Nitrogen@Arsenic@Phosphorus@Barium@Praseodymium@Bismuth@Rubidium@Cadmium@Selenium@Carbon@Silver@Cerium@Strontium@Cesium@Sulfur@Chromium@Tellurium@Cobalt@Tin@Copper@Titanium@Germanium@Tungsten@Gold@Uranium@Holmium@Vanadium@Iron@Zinc@Lanthanum@Zirconium
EC / List no: 266-046-0 | CAS no: 65997-17-3
-
-
Carc. 2
Details
201-328-9
81-14-1
Carc. 2
Details
688-331-2
874967-67-6
Carc. 2
Details
432-240-0
12056-51-8
Carc. 2
Details
205-359-9
139-40-2
Carc. 2
Details
245-951-4
23950-58-5
Carc. 2
Details
606-168-7
189278-12-4
Carc. 2
Details
427-140-9
-
Carc. 2
Details
204-535-2
122-34-9
Carc. 2
Details
204-825-9
127-18-4
Carc. 2
Details
236-675-5
13463-67-7
Carc. 2
Details
603-146-9
126535-15-7
Carc. 2
Details
237-159-2
13674-87-8
Carc. 2
Details
200-484-5
60-57-1
Carc. 2; Acute Tox. 1; Acute Tox. 3; STOT RE 1
Details
203-870-1
111-44-4
Carc. 2; Acute Tox. 2; Acute Tox. 1
Details
201-778-6
87-86-5
Carc. 2; Acute Tox. 2; Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
Details
231-911-3
7778-73-6
Carc. 2; Acute Tox. 2; Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
Details
205-025-2
131-52-2
Carc. 2; Acute Tox. 2; Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
Details
203-472-8
107-20-0
Carc. 2; Acute Tox. 2; Acute Tox. 3; Skin Corr. 1B
Details
608-723-9
32289-58-0
Carc. 2; Acute Tox. 2; Acute Tox. 4; STOT RE 1; Eye Dam. 1; Skin Sens. 1B
Details
608-042-7
27083-27-8
Carc. 2; Acute Tox. 2; Acute Tox. 4; STOT RE 1; Eye Dam. 1; Skin Sens. 1B
Details
202-039-0
91-08-7
Carc. 2; Acute Tox. 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
Details
209-544-5
584-84-9
Carc. 2; Acute Tox. 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
Details
247-722-4
26471-62-5
Carc. 2; Acute Tox. 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
Details
217-588-1
1897-45-6
Carc. 2; Acute Tox. 2; STOT SE 3; Eye Dam. 1; Skin Sens. 1
Details
202-765-8
99-55-8
Carc. 2; Acute Tox. 3
Details
256-960-8
51085-52-0
Carc. 2; Acute Tox. 3
Details
205-601-3
143-50-0
Carc. 2; Acute Tox. 3
Details
204-493-5
121-69-7
Carc. 2; Acute Tox. 3
Details
617-373-6
82657-04-3
Carc. 2; Acute Tox. 3; Acute Tox. 2; STOT RE 1; Skin Sens. 1B
Details
210-168-9
608-73-1
Carc. 2; Acute Tox. 3; Acute Tox. 4
Details
252-615-0
35554-44-0
Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Dam. 1
Details
219-397-9
2431-50-7
Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
Details
202-627-7
98-01-1
Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
Details
202-626-1
98-00-0
Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3
Details
252-626-0
35575-96-3
Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 1; Skin Sens. 1
Details
232-283-3
8001-35-2
Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Skin Irrit. 2
Details
202-709-2
98-87-3
Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
Details
205-087-0
133-06-2
Carc. 2; Acute Tox. 3; Eye Dam. 1; Skin Sens. 1
Details
203-403-1
106-49-0
Carc. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
Details
208-741-3
540-25-0
Carc. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
Details
208-740-8
540-23-8
Carc. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
Details
206-215-8
309-00-2
Carc. 2; Acute Tox. 3; STOT RE 1
Details
200-262-8
56-23-5
Carc. 2; Acute Tox. 3; STOT RE 1
Details
200-024-3
50-29-3
Carc. 2; Acute Tox. 3; STOT RE 1
Details
200-962-3
76-44-8
Carc. 2; Acute Tox. 3; STOT RE 2
Details
213-831-0
1024-57-3
Carc. 2; Acute Tox. 3; STOT RE 2
Details
219-006-1
2312-35-8
Carc. 2; Acute Tox. 3; Skin Irrit. 2; Eye Dam. 1
Details
245-430-1
23103-98-2
Carc. 2; Acute Tox. 3; Skin Sens. 1
Details
201-166-9
79-00-5
Carc. 2; Acute Tox. 4
Details
243-420-1
19900-65-3
Carc. 2; Acute Tox. 4
Details
201-990-9
90-41-5
Carc. 2; Acute Tox. 4
Details
200-555-0
63-25-2
Carc. 2; Acute Tox. 4
Details
200-349-0
57-74-9
Carc. 2; Acute Tox. 4
Details
228-200-5
6164-98-3
Carc. 2; Acute Tox. 4
Details
243-269-1
19750-95-9
Carc. 2; Acute Tox. 4
Details
218-961-1
2303-16-4
Carc. 2; Acute Tox. 4
Details
205-766-1
150-68-5
Carc. 2; Acute Tox. 4
Details
202-049-5
91-20-3
Carc. 2; Acute Tox. 4
Details
618-075-9
87820-88-0
Carc. 2; Acute Tox. 4
Details
200-819-5
74-88-4
Carc. 2; Acute Tox. 4; Acute Tox. 3; STOT SE 3; Skin Irrit. 2
Details
208-953-6
548-62-9
Carc. 2; Acute Tox. 4; Eye Dam. 1
Details
207-762-5
492-80-8
Carc. 2; Acute Tox. 4; Eye Irrit. 2
Details
601-613-1
119446-68-3
Carc. 2; Acute Tox. 4; Eye Irrit. 2
Details
-
-
Carc. 2; Acute Tox. 4; Eye Irrit. 2
Details
225-768-6
5064-31-3
Carc. 2; Acute Tox. 4; Eye Irrit. 2
Details
201-126-0
78-59-1
Carc. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3
Details
201-798-5
88-10-8
Carc. 2; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
Details
201-795-9
88-06-2
Carc. 2; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
Details
205-088-6
133-07-3
Carc. 2; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
Details
219-799-4
2536-05-2
Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
Details
202-966-0
101-68-8
Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
Details
247-714-0
26447-40-5
Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
Details
227-534-9
5873-54-1
Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1
Details
201-800-4
88-12-0
Carc. 2; Acute Tox. 4; STOT RE 2; STOT SE 3; Eye Dam. 1
Details
ITC 826 CONCENTRATE
422-720-8
166242-53-1
Carc. 2; Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1
Details
223-404-0
3878-19-1
Carc. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1
Details
405-060-5
118712-89-3
Carc. 2; Acute Tox. 4; STOT SE 1
Details
214-619-0
1166-46-7
Carc. 2; Acute Tox. 4; STOT SE 2
Details
428-790-6
72963-72-5
Carc. 2; Acute Tox. 4; STOT SE 2
Details
231-711-6
7696-12-0
Carc. 2; Acute Tox. 4; STOT SE 2
Details
201-758-7
87-62-7
Carc. 2; Acute Tox. 4; STOT SE 3; Skin Irrit. 2
Details
432-440-8
220444-73-5
Carc. 2; Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
Details
204-800-2
126-73-8
Carc. 2; Acute Tox. 4; Skin Irrit. 2
Details
B1; N,N-DIMETHYLANILINUM TETRAKIS(PENTAFLUOROPHENYL)BORATE; TÉTRAKIS(PENTAFLUOROPHÉNYL)BORATE DE N,N-DIMÉTHYLANILINIUM
422-050-6
118612-00-3
Carc. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
Details
240-110-8
15972-60-8
Carc. 2; Acute Tox. 4; Skin Sens. 1
Details
219-991-8
2593-15-9
Carc. 2; Acute Tox. 4; Skin Sens. 1
Details
420-450-5
86552-32-1
Carc. 2; Eye Dam. 1
Details
203-400-5
106-46-7
Carc. 2; Eye Irrit. 2
Details
672-776-4
348635-87-0
Carc. 2; Eye Irrit. 2
Details
215-204-7
1313-27-5
Carc. 2; Eye Irrit. 2; STOT SE 3
Details
620-358-7
140-41-0
Carc. 2; Eye Irrit. 2; Skin Irrit. 2
Details
239-213-0
15159-40-7
Carc. 2; Eye Irrit. 2; Skin Irrit. 2
Details
205-223-9
135-88-6
Carc. 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
204-961-9
129-73-7
Carc. 2; Muta. 2
Details
202-430-6
95-54-5
Carc. 2; Muta. 2; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
Details
210-418-7
615-28-1
Carc. 2; Muta. 2; Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1
Details
200-539-3
62-53-3
Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Skin Sens. 1
Details
show/hide
Dianilinium sulphate EC / List no: 208-805-0 | CAS no: 542-16-5
Aniline EC / List no: 200-539-3 | CAS no: 62-53-3
Anilinium chloride EC / List no: 205-519-8 | CAS no: 142-04-1
Anilinetrifluoroboron EC / List no: 211-539-8 | CAS no: 660-53-7
Phthalic acid, compound with aniline (1:1) EC / List no: 256-856-2 | CAS no: 50930-79-5
Anilinium bromide EC / List no: 208-801-9 | CAS no: 542-11-0
Anilinium acetate EC / List no: 208-802-4 | CAS no: 542-14-3
Anilinium dihydrogen phosphate EC / List no: 253-680-8 | CAS no: 37832-42-1
Anilinium p-tolylsulphonate EC / List no: 237-870-8 | CAS no: 14034-57-2
-
-
Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 1; Eye Dam. 1; Skin Sens. 1
Details
202-809-6
100-00-5
Carc. 2; Muta. 2; Acute Tox. 3; STOT RE 2
Details
204-617-8
123-31-9
Carc. 2; Muta. 2; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
Details
CIB R634
406-220-7
65322-65-8
Carc. 2; Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1
Details
245-740-7
23564-05-8
Carc. 2; Muta. 2; Acute Tox. 4; Skin Sens. 1
Details
212-668-2
842-07-9
Carc. 2; Muta. 2; Skin Sens. 1
Details
204-064-2
115-09-3
Carc. 2; Repr. 1A; Lact.; Acute Tox. 2; STOT RE 1
Details
215-630-3
1335-32-6
Carc. 2; Repr. 1A; STOT RE 2
Details
406-850-2
133855-98-8
Carc. 2; Repr. 1B
Details
202-716-0
98-95-3
Carc. 2; Repr. 1B; Acute Tox. 3; STOT RE 1
R Toxic for reproduction (article 57c)
Details
240-286-6
16118-49-3
Carc. 2; Repr. 1B; Acute Tox. 4
Details
617-717-5
85509-19-9
Carc. 2; Repr. 1B; Acute Tox. 4
Details
R 7623 TECHNICAL
403-250-2
-
Carc. 2; Repr. 1B; Acute Tox. 4
Details
204-118-5
115-96-8
Carc. 2; Repr. 1B; Acute Tox. 4
R Toxic for reproduction (article 57c)
Details
601-147-9
111988-49-9
Carc. 2; Repr. 1B; Acute Tox. 4; Acute Tox. 3; STOT SE 3
Details
221-470-5
3108-42-7
Carc. 2; Repr. 1B; Lact.
R Toxic for reproduction (article 57c)
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
206-400-3
335-76-2
Carc. 2; Repr. 1B; Lact.
R Toxic for reproduction (article 57c)
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
-
3830-45-3
Carc. 2; Repr. 1B; Lact.
R Toxic for reproduction (article 57c)
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
-
4149-60-4
Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1
R Toxic for reproduction (article 57c)
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
223-320-4
3825-26-1
Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1
R Toxic for reproduction (article 57c)
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
206-801-3
375-95-1
Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1
R Toxic for reproduction (article 57c)
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
-
21049-39-8
Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1
R Toxic for reproduction (article 57c)
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
206-397-9
335-67-1
Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1
R Toxic for reproduction (article 57c)
PBT Persistent, Bioaccumulative and Toxic (article 57d)
Details
249-415-0
29081-56-9
Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.
Details
274-460-8
70225-14-8
Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.
Details
249-644-6
29457-72-5
Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.
Details
217-179-8
1763-23-1
Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.
Details
220-527-1
2795-39-3
Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact.
Details
616-995-5
8018-01-7
Carc. 2; Repr. 1B; STOT RE 2; Skin Sens. 1
Details
CP-166,221
428-010-4
82413-20-5
Carc. 2; Repr. 1B; Skin Sens. 1
Details
256-599-6
50471-44-8
Carc. 2; Repr. 1B; Skin Sens. 1
Details
632-619-2
881685-58-1
Carc. 2; Repr. 1B; Skin Sens. 1B
Details
239-592-2
15545-48-9
Carc. 2; Repr. 2
Details
817-852-1
1228284-64-7
Carc. 2; Repr. 2
Details
602-927-1
123312-89-0
Carc. 2; Repr. 2
Details
604-715-4
149979-41-9
Carc. 2; Repr. 2
Details
212-984-0
900-95-8
Carc. 2; Repr. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
Details
200-990-6
76-87-9
Carc. 2; Repr. 2; Acute Tox. 2; Acute Tox. 3; STOT RE 1; STOT SE 3; Skin Irrit. 2; Eye Dam. 1
Details
200-663-8
67-66-3
Carc. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 1; Eye Irrit. 2; Skin Irrit. 2
Details
206-992-3
420-04-2
Carc. 2; Repr. 2; Acute Tox. 3; STOT RE 2; Skin Corr. 1; Skin Sens. 1; Eye Dam. 1
Details
604-712-8
149961-52-4
Carc. 2; Repr. 2; Acute Tox. 4
Details
200-543-5
62-56-6
Carc. 2; Repr. 2; Acute Tox. 4
Details
PANTERA; QUIZALOFOP-P-TEFURYL
414-200-4
119738-06-6
Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2
Details
220-529-2
2797-51-5
Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1A
Details
218-661-0
2212-67-1
Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2; Skin Sens. 1
Details
251-899-3
34256-82-1
Carc. 2; Repr. 2; Acute Tox. 4; STOT SE 3; STOT RE 2; Skin Irrit. 2; Skin Sens. 1
Details
204-385-8
120-32-1
Carc. 2; Repr. 2; Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1; Eye Dam. 1; STOT RE 2
Details
219-196-6
2385-85-5
Carc. 2; Repr. 2; Lact.; Acute Tox. 4
Details
701-225-3
1101132-67-5
Carc. 2; Repr. 2; STOT RE 2
Details
217-465-2
1861-40-1
Carc. 2; Repr. 2; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1
Details
604-105-8
139001-49-3
Carc. 2; Repr. 2; Skin Sens. 1
Details
202-112-7
91-97-4
Carc. 2; Resp. Sens. 1; Skin Sens. 1A
Details
200-925-1
76-01-7
Carc. 2; STOT RE 1
Details

Export search results to: